Table 2.
Demographics and preoperative data for patients undergoing hepatic resection during March 2005 to June 2011
| Variable (n = 128 resections) | Value |
|---|---|
| Age, years, median (range) | 63 (35–82) |
| Cirrhosis, n (%) | 4 (3%) |
| ASA score of 1 or 2, n (%) | 104 (81%) |
| Diagnosis, n (%) | |
| Colorectal metastases | 84 (66%) |
| Cholangiocarcinoma | 11 (9%) |
| Hepatocellular carcinoma | 9 (7%) |
| Gastrointestinal stromal tumour metastases | 3 (2%) |
| Carcinoid metastases | 4 (3%) |
| Other: benign/malignant | 10/8 (8%/6%) |
| Intraoperative factors, n (%) | |
| Major hepatectomy | 64 (50%) |
| Anastomosis | 10 (8%) |
| Epidural/intrathecal morphine/neither | 9/111/8 (7%/87%/6%) |
| Wound catheter: nil/continuous/intermittent | 28/51/49 (22%/40%/38%) |
| Nasogastric tube | 8 (6%) |
| Drain | 25 (20%) |
| Blood loss, <0.5 l/0.5–1.0 l/>1.0 l | 86/33/9 (67%/26%/7%) |
| Intraoperative transfusiona, units, median (range) | 0 (0–5) |
a
Fifteen of 128 (11.7%) patients who underwent a hepatic resection received a transfusion intraoperatively.
ASA, American Society of Anesthesiologists.